Imidazopyridine-based kinase inhibitors as potential anticancer agents: A review

F Peytam, Z Emamgholipour, A Mousavi, M Moradi… - Bioorganic …, 2023 - Elsevier
Considering the fundamental role of protein kinases in the mechanism of protein
phosphorylation in critical cellular processes, their dysregulation, especially in cancers, has …

[HTML][HTML] Cost in the United States of FDA-approved small molecule protein kinase inhibitors used in the treatment of neoplastic and non-neoplastic diseases

R Roskoski Jr - Pharmacological Research, 2024 - Elsevier
Because genetic alterations including mutations, overexpression, translocations, and
dysregulation of protein kinases are involved in the pathogenesis of many illnesses, this …

A review of FLT3 kinase inhibitors in AML

C Negotei, A Colita, I Mitu, AR Lupu… - Journal of Clinical …, 2023 - mdpi.com
Acute myeloid leukemia (AML) is a highly aggressive illness distinguished by the
accumulation of abnormal hematopoietic precursors in both the bone marrow and peripheral …

Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemia

HAA Ezelarab, TFS Ali, SH Abbas, HA Hassan… - BMC chemistry, 2023 - Springer
Fms-like tyrosine kinase 3 (FLT3) mutation mechanisms are among the most common
genetic abnormalities detected in about 30% of acute myeloid leukemia (AML) patients …

Mechanisms associated with t (7; 12) acute myeloid leukaemia: from genetics to potential treatment targets

D Ragusa, L Dijkhuis, C Pina, S Tosi - Bioscience Reports, 2023 - portlandpress.com
Acute myeloid leukaemia (AML), typically a disease of elderly adults, affects 8 children per
million each year, with the highest paediatric incidence in infants aged 0–2 of 18 per million …

Flavones, Flavonols, Lignans, and Caffeic Acid Derivatives from Dracocephalum moldavica and Their In Vitro Effects on Multiple Myeloma and Acute Myeloid …

K Jöhrer, M Galarza Pérez, B Kircher… - International journal of …, 2022 - mdpi.com
Phenolic plant constituents are well known for their health-promoting and cancer
chemopreventive properties, and products containing such constituents are therefore readily …

[HTML][HTML] Molecular precision medicine: Multi-omics-based stratification model for acute myeloid leukemia

T Wang, S Cui, C Lyu, Z Wang, Z Li, C Han, W Liu… - Heliyon, 2024 - cell.com
Acute myeloid leukemia (AML), as the most common malignancy of the hematopoietic
system, poses challenges in treatment efficacy, relapse, and drug resistance. In this study …

Strategies for the treatment of acute myeloid leukemia with FLT3 mutations: a patent review

L Gorecki, E Reznickova, V Krystof… - Expert Opinion on …, 2025 - Taylor & Francis
Introduction Approximately one-third of all AML patients have a mutation in the Fms-like
tyrosine kinase 3 (FLT3) gene, which is associated with a poor prognosis in these …

[HTML][HTML] Targeting FMS-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia: Novel molecular approaches and therapeutic challenges

J Rataj, L Gorecki, D Muthna, A Sorf, V Krystof… - Biomedicine & …, 2025 - Elsevier
Acute myeloid leukemia (AML), a heterogeneous hematologic malignancy, has generally a
poor prognosis despite the recent advancements in diagnostics and treatment. Genetic …

Recent studies on protein kinase signaling inhibitors based on thiazoles: review to date

MS Ebaid, HAA Ibrahim, AF Kassem, A Sabt - RSC advances, 2024 - pubs.rsc.org
Due to the important role of protein kinases in protein phosphorylation within vital cellular
processes, their abnormal function, especially in cancer situations, has underscored their …